filmov
tv
Leveraging the Power of Anti-CD20 mAbs in Patient-Centric Multiple Sclerosis Care
Показать описание
PeerView CME
CME
meded
neurology
multiple sclerosis
MS
Рекомендации по теме
0:29:38
Leveraging the Power of Anti-CD20 mAbs in Patient-Centric Multiple Sclerosis Care
0:03:27
What are the benefits of adding anti-CD20 therapy to treatment with targeted agents in CLL?
0:03:24
ADI-001: anti-CD20 CAR-engineered allogeneic γδ T cells in adults with B-cell malignancies
0:03:23
Determining the favorable clinical course in MS
0:08:14
#Alemtuzumab | Uses, Dosage, Side Effects and Mechanism | Campath
0:03:36
Herpes Zoster.
0:01:41
Ublituximab: pending approval for relapsing MS
0:02:10
Understanding Multiple Sclerosis | Dr. Rajiv Anand | BLK-Max Hospital, New Delhi
0:54:27
dkNET Webinar: Leveraging Computational Strategies to Identify Type 1 Diabetes Risk and...05/19/2023
0:07:27
What is #Monkeypox| How to treat #monkeypox| Answer all questions
0:01:56
Multiple Sclerosis and ACRM
0:39:50
Study design: How and when to use multiplexed immunofluorescence imaging in your research
0:45:24
Analytical Tools to Evaluate CAR-T Cell Signaling & Activation
1:02:23
Edward Stack - Using multiplexed IHC to effectively navigate the hidden...
1:00:39
Oncology Product Launch – The Toolkit for Success_2020_09_23
0:24:43
New IBD Therapies and Side Effects
0:03:51
Rheumatoid Arthritis & Physiotherapy
0:55:53
Mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology
1:02:10
Fine-Tuning the JAK/STAT Pathway in Psoriasis
0:31:02
Unlock Spatial Biology with Orion Technology: Explore the possibilities
0:59:34
Establishing Efficacy with Flow Cytometry- Based Receptor Occupancy Assays
0:10:09
Atara Biotherapeutics, Inc. (NASDAQ: ATRA)
0:20:14
Understanding Natural Killer Cells in Cancer Immunotherapies
0:31:02
Atara Biotherapeutics, Inc. (NASDAQ: ATRA)